Physician profile
Daniel B Fore
NPI 1407969843
$254,019.03
in general payments reported to CMS, 2019-2025
23 companies · $61K in 2025
The $61K reported for 2025 was more than what 99% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $37K · 2021: $37K · 2022: $40K · 2023: $51K · 2024: $18K · 2025: $61K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $116K · Food and Beverage: $8,501 · Travel and Lodging: $2,578 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,000 · Gift: $16.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $116,300.00 |
| Food and Beverage | $8,501.26 |
| Travel and Lodging | $2,577.76 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,000.00 |
| Gift | $16.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $248,896.10 | 2019-2025 | Da Vinci Surgical System, Da Vinci Sp |
| Medical Device Business Services, INC. | $4,371.28 | 2019-2022 | |
| Tela Bio, INC. | $184.29 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Davol INC. | $154.67 | 2021-2025 | Phasix Mesh |
| Acera Surgical, INC. | $51.89 | 2019-2020 | |
| Innovation Technologies INC | $41.88 | 2025 | Irrisept |
| Pacira Pharmaceuticals Incorporated | $34.16 | 2023 | Exparel |
| Integra Lifesciences Corporation | $30.60 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Z-Medica, LLC | $27.70 | 2020 | |
| Convatec INC. | $22.36 | 2024 | |
| Baxter Healthcare | $19.64 | 2021 | |
| Abbvie INC. | $18.56 | 2021 | |
| Cumberland Pharmaceuticals, INC. | $17.97 | 2020 | |
| Kci USA, INC. | $16.78 | 2019 | |
| Covidien Lp | $16.74 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $16.14 | 2023 | Aponvie |
| Lucid Diagnostics INC. | $15.76 | 2023 | |
| Avanos Medical | $15.73 | 2019 | |
| Teleflex LLC | $14.44 | 2019 | |
| Osiris Therapeutics INC. | $13.80 | 2019 | |
| Reprise Biomedical, INC. | $13.67 | 2021 | |
| Kerecis Limited | $12.70 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Ambu INC. | $12.17 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Fore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.